The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: carboplatin     Quarter: 2016Q3

Total Records: 1,176     Number of Pages: 59

DRUGNAME PT EventCount
Carboplatine Hospira Hypothermia 4
Carboplatine Hospira Infection 4
Carboplatine Hospira Oral disorder 4
Carboplatine Hospira Pseudolymphoma 4
Carboplatine Hospira Second primary malignancy 4
Carboplatino Hospira Gamma-glutamyltransferase increased 4
Carboplatino Hospira Pseudolymphoma 4
Carboplatino Hospira Transaminases increased 4
CARBOPLATINO TEVA - 10 MG/ML - TEVA PHARMA B.V. Erythema 4
CARBOPLATIN (Manufacturer Unknown) Fatigue 3
CARBOPLATIN (Manufacturer Unknown) Myalgia 3
CARBOPLATIN (Manufacturer Unknown) Thrombocytopenia 3
Carboplatin (Unknown) Diarrhoea 3
Carboplatin (Unknown) Neutropenia 3
Carboplatin (Unknown) Vomiting 3
CARBOPLATIN HOSPIRA General physical health deterioration 3
Carboplatin MYLAN Chest discomfort 3
Carboplatin MYLAN Febrile neutropenia 3
Carboplatin MYLAN Prinzmetal angina 3
CARBOPLATIN. Abscess 3

Total Records: 1,176     Number of Pages: 59